Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

被引：0
作者：
Yue-qin Wang
Ai-jun Shen
Jing-ya Sun
Xin Wang
Hong-chun Liu
Min-min Zhang
Dan-qi Chen
Bing Xiong
Jing-kang Shen
Mei-yu Geng
Min Zheng
Jian Ding
机构：
[1] China Pharmaceutical University,Department of New Drug Screening Center
[2] Division of Anti-tumor Pharmacology,Department of Thoracic Surgery
[3] Synthetic Organic and Medicinal Chemistry Laboratory,undefined
[4] State Key Laboratory of Drug Research,undefined
[5] Shanghai Institute of Materia Medica,undefined
[6] Chinese Academy of Sciences,undefined
[7] Shanghai Tongren Hospital,undefined
[8] Shanghai Jiao Tong University School of Medicine,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
non-small cell lung cancer; gefitinib resistance; Hsp90;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1587 / 1596
页数：9
相关论文
共 50 条
  • [21] Bone Metastasis in EGFR Mutant Non-Small Cell Lung Cancer
    Huang, Shu-Mei
    Yang, Jin-Ji
    Huang, Yi-Sheng
    Chen, Hua-Jun
    Bai, Xiao-Yan
    Zhou, Qing
    Tu, Han-Yan
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S766 - S767
  • [22] LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells
    Cho, Jung Hee
    You, Yeon-Mi
    Koo, Han
    Lee, Dong Chul
    Yeom, Young Il
    Park, Kyung Chan
    CANCERS, 2022, 14 (09)
  • [23] Crizotinib overcomes hepatocyte growth factor-mediated resistance to gefitinib in EGFR-mutant non-small-cell lung cancer cells
    Chen, Xi
    Zhou, Jian-Ya
    Zhao, Jing
    Chen, Jun-Jun
    Ma, Shan-Ni
    Zhou, Jian-Ying
    ANTI-CANCER DRUGS, 2013, 24 (10) : 1039 - 1046
  • [24] EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer
    Syrigos, K.
    Tsagouli, S.
    Gkiozos, I.
    Paraskeva, M.
    Kotteas, I.
    Tsimpoukis, S.
    Zontanos, M.
    Grapsa, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S903 - S903
  • [25] The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib
    Park, Kang-Seo
    Oh, Bora
    Lee, Mi-Hee
    Nam, Ky-Youb
    Jin, Hae Ran
    Yang, Hannah
    Choi, Junyoung
    Kim, Sang -We
    Lee, Dae Ho
    CANCER LETTERS, 2016, 372 (01) : 75 - 81
  • [26] Vorinostat enhances gefitinib-induced cell death through reactive oxygen species-dependent cleavage of HSP90 and its clients in non-small cell lung cancer with the EGFR mutation
    Park, Sang Eun
    Kim, Dong Eun
    Kim, Mi Joung
    Lee, Jee Suk
    Rho, Jin Kyung
    Jeong, Seong-Yun
    Choi, Eun Kyung
    Kim, Choung-Soo
    Hwang, Jung Jin
    ONCOLOGY REPORTS, 2019, 41 (01) : 525 - 533
  • [27] 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
    Zhang, Yi
    Yao, Ke
    Shi, Chengcheng
    Jiang, Yanan
    Liu, Kangdong
    Zhao, Song
    Chen, Hanyong
    Reddy, Kanamata
    Zhang, Chengjuan
    Chang, Xiaoyu
    Ryu, Joohyun
    Bode, Ann M.
    Dong, Ziming
    Dong, Zigang
    ONCOTARGET, 2015, 6 (42) : 44274 - 44288
  • [28] Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer
    Hidayat, Moulid
    Mitsuishi, Yoichiro
    Takahashi, Fumiyuki
    Tajima, Ken
    Yae, Toshifumi
    Miyahara, Katsumi
    Hayakawa, Daisuke
    Winardi, Wira
    Ihara, Hiroaki
    Koinuma, Yoshika
    Wirawan, Aditya
    Nurwidya, Fariz
    Kato, Motoyasu
    Kobayashi, Isao
    Sasaki, Shinichi
    Takamochi, Kazuya
    Hayashi, Takuo
    Suehara, Yoshiyuki
    Moriyama, Mariko
    Moriyama, Hiroyuki
    Habu, Sonoko
    Takahashi, Kazuhisa
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 19 (04) : 355 - 367
  • [29] HSP90 as a novel molecular target in non-small-cell lung cancer
    Esfahani, Khashayar
    Cohen, Victor
    LUNG CANCER-TARGETS AND THERAPY, 2016, 7 : 11 - 17
  • [30] Overcoming Erlotinib Resistance in EGFR Mutation-Positive Non-Small Cell Lung Cancer Cells by Targeting Survivin
    Okamoto, Kunio
    Okamoto, Isamu
    Hatashita, Erina
    Kuwata, Kiyoko
    Yamaguchi, Haruka
    Kita, Aya
    Yamanaka, Kentaro
    Ono, Mayumi
    Nakagawa, Kazuhiko
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (01) : 204 - 213
12345